End-Stage Renal Disease (ESRD) Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
End-Stage Renal Disease (ESRD) Treatment Market is segmented By Treatment Modality (Hemodialysis, Peritoneal Dialysis, Kidney Transplantation), By Product Type (Dialysis ....
End-Stage Renal Disease (ESRD) Treatment Market Size
Market Size in USD
CAGR5.2%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.2% |
| Market Concentration | High |
| Major Players | Fresenius Medical Care, DaVita Inc., Baxter International Inc., Nipro Corporation, B. Braun Melsungen AG |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
End-Stage Renal Disease (ESRD) Treatment Market Analysis
The end-stage renal disease (ESRD) treatment market is estimated to be valued at USD 84.7 Bn in 2024 and is expected to reach USD 120.9 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031. The aging population and growing prevalence of chronic kidney diseases around the world is expected to propel the demand for ESRD treatment in the forecast period.